7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-09-30 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 
      
    		                                                  
      cash flows from operating activities:
    		                                                  
      net income
    		436,000,000 495,000,000 600,000,000 602,000,000 492,000,000 476,000,000 498,000,000 434,000,000 369,000,000 427,000,000 509,000,000 439,000,000 301,000,000 323,000,000 446,000,000 429,000,000 307,000,000 355,000,000 312,000,000 209,000,000 172,000,000 169,000,000 268,000,000                            
      adjustments to reconcile net income to net cash from operating activities:
    		                                                  
      depreciation and amortization
    		49,000,000 47,000,000 47,000,000 47,000,000 45,000,000 45,000,000 42,000,000 42,000,000 42,000,000 41,000,000 40,000,000 40,000,000 36,000,000 34,000,000 35,000,000 37,000,000 33,000,000 32,000,000 32,000,000 31,000,000 30,000,000 28,000,000 30,000,000 31,000,000 28,000,000 27,000,000 26,000,000 26,805,000 25,145,000 23,496,000 23,289,000 21,983,000 21,190,000 21,018,000 19,941,000 18,419,000 18,312,000 17,743,000 17,909,000 17,264,000 17,122,000 16,005,000 13,366,000 18,026,000 10,082,000 9,971,000 10,007,000 10,528,000 19,792,426 9,574 
      deferred income taxes
    		-50,000,000 11,000,000 35,000,000 -55,000,000 -2,000,000 -17,000,000 -9,000,000 -66,000,000 -18,000,000 -29,000,000 25,000,000 -39,000,000 11,000,000 -2,000,000 14,000,000 -13,000,000 -51,000,000 9,000,000 18,000,000 -26,000,000 1,000,000 -30,000,000 16,000,000 -1,000,000 -21,000,000 -7,000,000 6,000,000 17,703,000 -6,342,000 -16,085,000 121,273,000 45,331,000 -18,767,000 -49,109,000 10,928,000 -24,941,000 -20,562,000 -19,926,000 6,631,000 565,000 2,250,000 -9,017,000 18,433,000 -6,356,000 411,000 -10,444,000 37,234,000 -17,394,000 -25,829,263 -18,737 
      premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments
    		-18,000,000                                                  
      provisions for credit losses and legal and regulatory matters
    		83,000,000 17,000,000 7,000,000    7,000,000                                            
      share-based compensation expense
    		52,000,000 54,000,000 93,000,000 53,000,000 54,000,000 57,000,000 90,000,000 45,000,000 54,000,000 57,000,000 81,000,000 43,000,000 40,000,000 44,000,000 65,000,000 29,000,000 29,000,000 31,000,000 43,000,000 23,000,000 23,000,000 31,000,000 43,000,000 24,000,000 23,000,000 28,000,000 37,000,000 22,330,000 22,156,000 24,151,000 34,417,000 19,745,000 10,404,000 25,470,000 40,545,000 15,649,000 18,042,000 20,335,000 22,400,000 14,136,000 16,843,000 17,647,000 13,955,000 11,434,000 12,930,000 17,410,000     
      unrealized gains on corporate-owned life insurance policies, net of expenses
    		                                                  
      other
    		2,000,000 -10,000,000 31,000,000 4,000,000 14,000,000 12,000,000 -8,000,000 11,000,000 2,000,000 7,000,000 -10,000,000 24,000,000 15,000,000 11,000,000 -1,000,000 19,000,000 16,000,000 9,000,000 22,000,000 88,000,000 8,000,000 -13,000,000 9,000,000 4,000,000 6,000,000 30,000,000 11,000,000 3,188,000 8,300,000 7,666,000 5,693,000 11,403,000 20,196,000 3,423,000 -5,490,000 1,854,000 14,509,000 13,346,000 6,881,000 32,614,000 5,776,000 26,121,000 -355,000 12,779,000 -2,137,000 827,000 25,934,000 21,334,000 -1,314,766 -2,234 
      net change in:
    		                                                  
      collateralized agreements, net of collateralized financings
    		-292,000,000 -3,000,000 48,000,000 -394,000,000 355,000,000 166,000,000 143,000,000 148,000,000 -177,000,000 89,000,000 97,000,000 -47,000,000 -49,000,000 -66,000,000 125,000,000 149,000,000 -179,000,000 63,000,000 -62,000,000                                
      loans (provided to) financial advisors, net of repayments
    		-92,000,000 -67,000,000 -35,000,000 -77,000,000 -80,000,000 -12,000,000 -54,000,000 -23,000,000 -18,000,000 9,000,000 25,000,000                                        
      brokerage client receivables and other receivables
    		-30,000,000 -471,000,000 331,000,000 147,000,000 60,000,000 -873,000,000 304,000,000 -199,000,000 311,000,000 -332,000,000 477,000,000 -146,000,000 242,000,000 -496,000,000 197,000,000                                    
      trading instruments
    		146,000,000 -3,000,000 -66,000,000 44,000,000 -21,000,000 -251,000,000 194,000,000 -95,000,000 -101,000,000 36,000,000 127,000,000 -78,000,000 -34,000,000 -49,000,000 209,000,000 -183,000,000 132,000,000 -112,000,000 22,000,000 -66,000,000   4,000,000 93,000,000 -16,000,000 -98,000,000 62,000,000 -54,298,000 77,400,000 -119,152,000 -46,547,000 -12,375,000 -104,598,000 -18,637,000 192,716,000 77,140,000 -81,610,000 -179,393,000 162,685,000 -5,455,000 11,778,000 -102,363,000 129,762,000 -71,539,000 51,365,000 -6,712,000 -18,894,000 13,357,000 86,210,886 66,114 
      derivative instruments
    		-85,000,000 -86,000,000 202,000,000 -186,000,000 120,000,000 81,000,000 -166,000,000 94,000,000 -102,000,000 -104,000,000 -18,000,000 233,000,000 80,000,000 108,000,000 58,000,000 12,000,000 -50,000,000 100,000,000 -9,000,000 17,000,000 -43,000,000 -77,000,000 52,000,000 -7,000,000 -44,000,000 -33,000,000 -60,000,000 -3,918,000 30,504,000 15,897,000 30,449,000                    
      other assets
    		55,000,000 5,000,000 18,000,000 27,000,000 15,000,000 7,000,000 -40,000,000 -9,000,000 22,000,000 -73,000,000 8,000,000 -29,000,000 -58,000,000 392,000,000 -431,000,000 254,000,000 -215,000,000 507,000,000 -530,000,000 51,000,000 112,000,000 -95,000,000 -81,000,000 -2,000,000 35,000,000 -96,000,000 -22,000,000 76,183,000 454,000 -30,467,000 -18,799,000                    
      brokerage client payables and other payables
    		293,000,000 -81,000,000 119,000,000 19,000,000 -511,000,000 422,000,000 161,000,000 -324,000,000 -872,000,000 -1,010,000,000 -3,882,000,000 -7,198,000,000 -3,571,000,000 1,535,000,000 5,021,000,000                                    
      accrued compensation, commissions and benefits
    		298,000,000 122,000,000 -529,000,000 345,000,000 219,000,000 263,000,000 -423,000,000 218,000,000 237,000,000 179,000,000 -511,000,000 185,000,000 17,000,000 117,000,000 -395,000,000 256,000,000 189,000,000 224,000,000 -253,000,000 231,000,000 179,000,000 0 -340,000,000 179,000,000 130,000,000 160,000,000 -389,000,000 183,534,000 104,970,000 109,518,000 -266,453,000 177,155,000 91,133,000 109,784,000 -218,034,000 151,015,000 64,232,000 73,919,000 -242,815,000 96,752,000 57,012,000 117,221,000 99,578,000 50,940,000 70,843,000 -161,374,000 17,153,000 71,694,000 -54,537,444 -122,556 
      purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale
    		-57,000,000 53,000,000 -67,000,000 -22,000,000 -24,000,000 102,000,000 -97,000,000 40,000,000 3,000,000 72,000,000 -66,000,000 51,000,000 135,000,000 -110,000,000 -43,000,000 -4,000,000 66,000,000 19,000,000 -86,000,000                 -39,575,000 1,600,000 10,898,000 -74,078,000  -23,577,000          
      net cash from operating activities
    		691,000,000 117,000,000 830,000,000       -624,000,000 -3,136,000,000 -4,498,000,000    4,501,000,000 1,408,000,000 -1,188,000,000 1,904,000,000   2,397,000,000 546,000,000   -205,000,000 225,000,000  2,116,000 661,414,000 325,619,000   284,364,000 807,775,000 -431,102,000 -19,372,000 -295,259,000 227,409,000 434,391,000 84,100,000 56,667,000 175,502,000 146,717,000 89,061,000 -19,991,000 468,286,000 -42,822,000 1,131,764,551 1,212,449 
      capex
    		-57,000,000 -46,000,000 -41,000,000       -42,000,000 -27,000,000 -23,000,000    25,000,000 -37,000,000 -37,000,000 -25,000,000   -35,000,000 -36,000,000   -32,000,000 -27,000,000  0 0 0   -44,679,000 -78,659,000 -35,215,000 -28,338,000 -25,599,000 -32,581,000 -22,446,000 -22,022,000 -16,045,000 -23,943,000 -22,390,000 -17,535,000 -13,647,000 -9,030,000 -12,196,000 -15,964,500 -9,500 
      free cash flows
    		634,000,000 71,000,000 789,000,000       -666,000,000 -3,163,000,000 -4,521,000,000    4,526,000,000 1,371,000,000 -1,225,000,000 1,879,000,000   2,362,000,000 510,000,000   -237,000,000 198,000,000  2,116,000 661,414,000 325,619,000   239,685,000 729,116,000 -466,317,000 -47,710,000 -320,858,000 194,828,000 411,945,000 62,078,000 40,622,000 151,559,000 124,327,000 71,526,000 -33,638,000 459,256,000 -55,018,000 1,115,800,051 1,202,949 
      cash flows from investing activities:
    		                                                  
      increase in bank loans
    		-1,710,000,000 -1,040,000,000 -1,294,000,000 -862,000,000 -1,267,000,000 -65,000,000 -405,000,000 -500,000,000 -141,000,000 205,000,000 -826,000,000 -1,858,000,000 -2,527,000,000 -1,713,000,000 -1,137,000,000 -1,407,000,000 -1,098,000,000 -818,000,000 -704,000,000 -158,000,000 88,000,000 -701,000,000 -365,000,000 -379,000,000 -447,000,000 -318,000,000 -461,000,000 -943,133,000 -637,573,000 -592,531,000 -645,197,000 -463,580,000 -686,549,000 -321,057,000 -782,388,000 -498,356,000 -489,306,000 -720,516,000 -770,371,000 -1,104,810,000 183,182,000 -582,459,000         
      proceeds from sales of loans held for investment
    		135,000,000 21,000,000 62,000,000 78,000,000 173,000,000 88,000,000 76,000,000 80,000,000 458,000,000 97,000,000 45,000,000 22,000,000 57,000,000 59,000,000 75,000,000 39,000,000 158,000,000 74,000,000 16,000,000 362,000,000 247,000,000 0 25,000,000 25,000,000 26,000,000 55,000,000 129,000,000 52,679,000 49,731,000 69,167,000 21,580,000 45,461,000 181,446,000 52,060,000 54,163,000 80,821,000 51,293,000 30,068,000 35,375,000 47,558,000 21,918,000 32,503,000         
      purchases of available-for-sale securities
    		-180,000,000 -92,000,000 -208,000,000 -106,000,000 -49,000,000 -297,000,000 -51,000,000 -50,000,000 -236,000,000 -172,000,000 -153,000,000 -326,000,000 -751,000,000 -1,168,000,000 -824,000,000 -1,137,000,000 -808,000,000 -1,030,000,000 -1,243,000,000 -2,563,000,000 -1,744,000,000 -1,089,000,000 -314,000,000 -338,000,000 -180,000,000 -218,000,000 -291,000,000 -224,960,000 -244,396,000 -315,267,000 -339,580,000 -308,084,000                   
      available-for-sale securities maturations, repayments and redemptions
    		522,000,000 503,000,000 506,000,000 731,000,000 546,000,000 438,000,000 295,000,000 285,000,000 338,000,000 313,000,000 326,000,000 366,000,000 394,000,000 451,000,000 501,000,000 523,000,000 591,000,000 523,000,000 544,000,000 444,000,000 309,000,000 229,000,000 206,000,000 188,000,000 161,000,000 144,000,000 151,000,000 135,928,000 125,120,000 120,278,000 114,139,000 100,689,000                   
      proceeds from sales of available-for-sale securities
    		0 0 78,000,000         50,000,000    0 450,000,000 0 519,000,000 0            28,118,000                   
      additions to property and equipment
    		-57,000,000 -46,000,000 -41,000,000 -50,000,000 -56,000,000 -49,000,000 -50,000,000 -51,000,000 -53,000,000 -42,000,000 -27,000,000 -23,000,000 -26,000,000 -23,000,000 -19,000,000 25,000,000 -37,000,000 -37,000,000 -25,000,000 -27,000,000 -26,000,000 -35,000,000 -36,000,000 -36,000,000 -43,000,000 -32,000,000 -27,000,000      -29,507,000 -44,679,000 -78,659,000 -35,215,000 -28,338,000 -25,599,000 -32,581,000 -22,446,000 -22,022,000 -16,045,000 -23,943,000 -22,390,000 -17,535,000 -13,647,000 -9,030,000 -12,196,000 -15,964,500 -9,500 
      sales/(purchases) of federal reserve bank (“frb”) and federal home loan bank (“fhlb”) stock
    		-1,000,000                                                  
      renewable energy tax credit equity investments
    		                                                  
      other investing activities
    		-11,000,000 -14,000,000 -40,000,000 5,000,000 4,000,000 -47,000,000 -26,000,000 -8,000,000 -17,000,000 -13,000,000 -31,000,000 -12,000,000 -10,000,000 -45,000,000 -26,000,000 -5,000,000 24,000,000 1,000,000 -12,000,000 -23,000,000 -21,000,000 8,000,000 -18,000,000 29,000,000 12,000,000 -8,000,000 -34,000,000 -6,777,000 49,858,000 12,026,000 -29,669,000 -1,212,000                   
      net cash from investing activities
    		-1,302,000,000 -659,000,000 -937,000,000   67,000,000 -176,000,000   347,000,000 -666,000,000 -2,032,000,000 -2,716,000,000 -848,000,000 -1,555,000,000 -1,983,000,000 -720,000,000 -1,314,000,000 -1,123,000,000 -1,965,000,000 -930,000,000 -1,588,000,000 -502,000,000 -511,000,000 -476,000,000 -377,000,000 -533,000,000 -978,286,000 -682,936,000 -740,816,000 -1,073,876,000 -647,334,000 -793,734,000 -829,853,000 -1,105,149,000 -942,673,000 -435,386,000 -747,047,000 -856,713,000 -1,233,554,000 331,241,000 -529,336,000 -222,614,000 -1,456,008,000 -608,285,000 -444,308,000 -396,221,000 -105,477,000 101,577,002 -22,002 
      cash flows from financing activities:
    		                                                  
      increase in bank deposits
    		846,000,000   1,609,000,000 -442,000,000 -550,000,000 1,194,000,000  -461,000,000 2,250,000,000 622,000,000 1,469,000,000 2,610,000,000 593,000,000 1,597,000,000 2,155,000,000 1,086,000,000 1,464,000,000 989,000,000 1,429,000,000 -4,651,000,000 7,048,000,000 694,000,000 115,000,000 548,000,000 -55,000,000 1,731,000,000 462,946,000 766,658,000 -13,642,000 993,183,000 1,421,481,000 -66,663,000 1,187,754,000 927,243,000 530,353,000 1,002,737,000 71,848,000 737,728,000 909,265,000 -261,397,000 -238,914,000 322,409,000 363,458,000       
      repurchases of common stock and share-based awards withheld for payment of withholding tax requirements
    		-455,000,000 -274,000,000 -185,000,000 -329,000,000 -243,000,000 -213,000,000 -199,000,000  -302,000,000 -369,000,000 -189,000,000 -56,000,000 -101,000,000 -8,000,000 -51,000,000                                    
      dividends on common and preferred stock
    		-103,000,000 -106,000,000 -105,000,000 -95,000,000 -95,000,000 -96,000,000 -97,000,000                                            
      exercise of stock options and employee stock purchases
    		7,000,000 9,000,000 10,000,000 9,000,000 9,000,000 18,000,000 10,000,000  12,000,000 14,000,000 11,000,000 8,000,000 12,000,000 15,000,000 17,000,000 11,000,000 10,000,000 14,000,000 18,000,000 7,000,000 12,000,000 18,000,000 25,000,000 12,000,000 10,000,000 20,000,000 23,000,000 8,652,000 10,551,000 18,190,000 25,954,000 6,279,000 7,194,000 19,846,000 24,143,000 6,481,000 5,610,000 16,854,000 14,386,000 7,071,000 6,367,000 4,876,000 10,395,000 7,272,000 13,502,000 2,642,000 6,740,000 3,441,000 37,184,975 17,025 
      proceeds from fhlb advances
    		300,000,000 0 450,000,000 0                                               
      repayments of fhlb advances
    		-300,000,000 -200,000,000 -450,000,000                                                
      other financing
    		-3,000,000 2,000,000 -7,000,000 0 -1,000,000 0 -1,000,000  0 -1,000,000 -1,000,000 -2,000,000 0 0 -5,000,000 -3,000,000                                   
      net cash from financing activities
    		     -641,000,000 907,000,000  -1,433,000,000 2,301,000,000 221,000,000 1,281,000,000 2,573,000,000 528,000,000 1,497,000,000 2,105,000,000 880,000,000 1,361,000,000 908,000,000 1,335,000,000 -4,693,000,000 7,297,000,000 654,000,000 -137,000,000 411,000,000 -427,000,000 1,526,000,000 378,078,000 730,037,000 -667,165,000 979,232,000 1,762,309,000 437,649,000 663,270,000 1,201,335,000 1,061,027,000 956,766,000 -88,470,000 649,410,000 816,610,000 -366,608,000 -163,276,000 296,138,000 163,564,000 1,477,504,000 -57,931,000 771,567,000 472,630,000 -2,920,653,890 -2,927,110 
      raymond james financial, inc. and subsidiaries condensed consolidated statements of cash flows
    		                                                  
      in millions
    		0 1,000,000 2,024,000,000  0 1,000,000 2,023,000,000  0 1,000,000 2,022,000,000 0 0 1,000,000 2,021,000,000 0 0 1,000,000 2,020,000,000 0 0 1,000,000 2,019,000,000 0 0 1,000,000 2,018,000,000                        
      currency adjustment:
    		                                                  
      effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes
    		197,000,000 65,000,000 -214,000,000  -11,000,000 -48,000,000 115,000,000  88,000,000 43,000,000 215,000,000                                        
      net increase/(decrease) in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash
    		-122,000,000 -493,000,000 -768,000,000  -970,000,000 -231,000,000 1,389,000,000       745,000,000 -2,342,000,000                                    
      cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year
    		0 0 14,348,000,000  0 0 12,548,000,000  0 0 14,659,000,000 0 0 0 16,449,000,000                                    
      cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period
    		-122,000,000 -493,000,000 13,580,000,000  -970,000,000 -231,000,000 13,937,000,000  -1,146,000,000 2,067,000,000 11,293,000,000  5,357,000,000 745,000,000 14,107,000,000                                    
      cash and cash equivalents
    		-467,000,000 -386,000,000 10,048,000,000  -906,000,000 -205,000,000 10,206,000,000  -288,000,000 2,486,000,000 6,177,000,000 220,000,000 243,000,000 -2,501,000,000 8,216,000,000 1,219,000,000 131,000,000 474,000,000 5,377,000,000 -242,000,000 -5,016,000,000 6,539,000,000 4,109,000,000 361,000,000 -235,000,000 -491,000,000 4,322,000,000                        
      cash and cash equivalents segregated for regulatory purposes and restricted cash
    		345,000,000 -107,000,000 3,532,000,000  -64,000,000 -26,000,000 3,731,000,000  -858,000,000 -419,000,000 5,116,000,000 -5,770,000,000 5,114,000,000 3,246,000,000 5,891,000,000                                    
      total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period
    		-122,000,000 -493,000,000 13,580,000,000  -970,000,000 -231,000,000 13,937,000,000  -1,146,000,000 2,067,000,000 11,293,000,000  5,357,000,000 745,000,000 14,107,000,000                                    
      supplemental disclosures of cash flow information:
    		                                                  
      cash paid for interest
    		446,000,000 449,000,000 499,000,000  526,000,000 550,000,000 499,000,000  375,000,000 267,000,000 216,000,000 186,000,000 61,000,000 35,000,000 41,000,000 32,000,000 37,000,000 41,000,000 35,000,000 46,000,000 26,000,000 53,000,000 39,000,000 75,000,000 61,000,000 85,000,000 62,000,000 73,859,000 43,297,000 55,746,000 28,026,000 63,054,000 15,940,000 44,548,000 32,442,000 27,888,000 30,142,000 29,188,000 26,421,000 25,926,000 27,307,000 25,116,000 40,046,000 15,096,000 25,096,000 11,215,000 19,145,000 3,622,000 32,556,213 8,787 
      cash paid for income taxes
    		137,000,000 364,000,000 9,000,000  175,000,000 349,000,000 24,000,000  147,000,000 376,000,000 13,000,000 138,000,000 93,000,000 281,000,000 12,000,000 102,000,000 87,000,000 181,000,000 67,000,000 44,000,000 26,000,000 167,000,000 9,000,000 95,000,000 107,000,000 178,000,000 10,000,000 39,376,000 109,087,000 74,158,000 8,515,000 105,424,000 98,913,000 130,962,000 13,710,000 93,004,000 86,268,000 90,604,000 33,917,000 66,997,000 102,360,000 61,068,000 52,824,000 13,227,000 100,351,000 10,137,000 39,958,000 35,525,000 118,743,312 6,688 
      cash outflows for lease liabilities
    		33,000,000 33,000,000 33,000,000  31,000,000 30,000,000 30,000,000  32,000,000 29,000,000 31,000,000 31,000,000 28,000,000 27,000,000 25,000,000 26,000,000 28,000,000 29,000,000 27,000,000                                
      non-cash right-of-use assets recorded for new and modified leases
    		24,000,000 21,000,000 33,000,000  26,000,000 8,000,000 17,000,000  70,000,000 29,000,000 13,000,000 29,000,000 13,000,000 10,000,000 16,000,000                                    
      unrealized (gains)/losses on company-owned life insurance policies, net of expenses
    		                                                  
      proceeds from short-term borrowings
    		                                                  
      net cash provided by/(used in) financing activities
    		 -16,000,000 -447,000,000                                                
      premium and discount amortization on available-for-sale securities and bank loans and net unrealized gain/loss on other investments
    		  -4,000,000 -6,000,000 -13,000,000 -5,000,000 -12,000,000 -12,000,000 -14,000,000 -12,000,000 -11,000,000                                        
      unrealized gain on company-owned life insurance policies, net of expenses
    		    -12,000,000 -75,000,000 -87,000,000    -48,000,000    -38,000,000 9,000,000   -83,000,000 -36,000,000    -1,000,000                           
      increase/(decrease) in bank deposits
    		  -160,000,000                                                
      adjustments to reconcile net income to net cash provided by/(used in) operating activities:
    		                                                  
      provisions for credit losses and legal and regulatory proceedings
    		        113,000,000          16,000,000                                
      unrealized (gain)/loss on company-owned life insurance policies, net of expenses
    		       29,000,000 -39,000,000   38,000,000 117,000,000         111,000,000 -35,000,000   -50,000,000 58,000,000                        
      assets segregated for regulatory purposes excluding cash and cash equivalents
    		           1,999,000,000 8,395,000,000 -795,000,000 -7,499,000,000                                    
      net cash provided by/(used in) operating activities
    		   510,000,000 711,000,000 391,000,000 543,000,000 434,000,000      1,117,000,000 -2,287,000,000         678,000,000        -108,479,000                   
      cash and cash equivalents acquired in business acquisitions, including those segregated for regulatory purposes, net of cash paid for acquisitions
    		           -308,000,000 98,000,000                                      
      (purchases)/sales of federal reserve bank (“frb”) and federal home loan bank (“fhlb”) stock
    		                                                  
      investment in note receivable
    		           0 0 0 -125,000,000                                    
      (purchases)/sales of other investments
    		           57,000,000                                       
      redemption of preferred stock
    		                                                  
      repayments of fhlb advances and other borrowed funds
    		   0                                               
      sales of federal reserve bank (“frb”) and federal home loan bank (“fhlb”) stock
    		                                                  
      investment in solar tax credit equity investment
    		    0 0 -15,000,000                                            
      purchases of other investments
    		        0                                          
      net cash provided by/(used in) investing activities
    		                                                  
      purchases of federal reserve bank and federal home loan bank stock
    		                                                  
      proceeds from federal home loan bank advances
    		     0 750,000,000  900,000,000 1,000,000,000 650,000,000 0 175,000,000       0 0 0 850,000,000 0    0    100,000,000 750,000,000 0 100,000,000 0 0 0 25,000,000            
      repayments of federal home loan bank advances and other borrowed funds
    		     0 -750,000,000  -1,450,000,000 -500,000,000 -791,000,000 -61,000,000 -54,000,000 -851,000,000 -1,000,000 -2,000,000 -1,000,000 -2,000,000 -26,000,000 -1,000,000 -1,000,000 -2,000,000 -851,000,000 -1,000,000   -1,000,000 -1,266,000   -1,186,000 -1,186,000 -651,170,000 -1,153,000 -1,138,000 -1,120,000 -1,106,000              
      provisions/(benefits) for credit losses and legal and regulatory proceedings
    		          21,000,000 39,000,000 56,000,000 24,000,000 -8,000,000 9,000,000 -15,000,000                                  
      losses on extinguishment of debt
    		               0                                   
      purchase of federal reserve bank stock
    		                                                  
      purchases of federal home loan bank stock
    		                                                  
      raymond james financial, inc. and subsidiaries
    		                                                  
      sales of federal home loan bank stock
    		                                                  
      dividends on preferred and common stock
    		        -92,000,000 -93,000,000 -81,000,000                                        
      common stock issued as consideration for tristate capital acquisition
    		           0                                       
      restricted stock awards issued as consideration for tristate capital acquisition
    		           0                                       
      preferred stock issued as consideration for tristate capital acquisition
    		                                                  
      effective settlement of note receivable for tristate capital acquisition
    		           0                                       
      purchase of federal home loan bank stock
    		                                                  
      net decrease in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash
    		         2,067,000,000 -3,366,000,000                                        
      loans provided to financial advisors, net of repayments
    		           -35,000,000 -9,000,000 -20,000,000 -56,000,000 -21,000,000 -58,000,000 -16,000,000 5,000,000 -26,000,000 -12,000,000 1,000,000 -12,000,000 -51,000,000 -29,000,000   -10,300,000 -50,553,000 -396,000 -21,928,000 -11,449,000 -8,391,000 -20,432,000 -13,513,000 -244,600,000 -29,350,000 -32,336,000 -38,500,000  -21,789,000          
      raymond james financial, inc. and subsidiaries consolidated statements of cash flows
    		                                                  
      proceeds from senior notes issuances, net of debt issuance costs paid
    		               0    0 -1,000,000                              
      extinguishment of senior notes payable
    		               0                -658,282,000                   
      cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year
    		                                                  
      total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year
    		                                                  
      premium and discount amortization on available-for-sale securities and net (gain)/loss on other investments
    		            16,000,000 10,000,000 14,000,000                                    
      dividends on common stock
    		            -69,000,000 -71,000,000 -60,000,000 -55,000,000 -54,000,000 -54,000,000 -55,000,000 -51,000,000 -51,000,000 -52,000,000 -51,000,000 -48,000,000 -48,000,000 -48,000,000 -47,000,000 -44,121,000 -36,587,000 -38,129,000 -32,499,000 -31,880,000 -32,295,000 -31,772,000 -31,255,000 -28,438,000 -28,845,000 -29,046,000 -27,106,000 -26,028,000 -27,710,000 -22,660,000 -18,127,000 -17,777,000 -16,479,000 -16,399,000 -13,744,000 -16,478,000 -32,851,613 -16,387 
      effect of exchange rate changes on cash
    		            -240,000,000 -52,000,000 3,000,000 -38,000,000 21,000,000 20,000,000 73,000,000 28,000,000 55,000,000 -103,000,000 21,000,000 -11,000,000 19,000,000 24,000,000 -55,000,000 6,585,000 -9,404,000 -11,024,000 -3,118,000 47,697,000 12,962,000 -9,730,000 -26,138,000 -14,857,000 -3,737,000 14,174,000 -24,724,000 1,478,000 -6,789,000 -10,749,000 1,959,000 -1,096,000 624,000 -511,000 -2,625,000 823,000 979,693 -1,693 
      net increase in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash
    		                                                  
      issuance of preferred stock as consideration for tristate capital acquisition
    		                                                  
      business acquisitions, net of cash acquired
    		               -21,000,000 0 -27,000,000 -218,000,000                                
      premium and discount amortization on available-for-sale securities and net gain/loss on other investments
    		                                                  
      goodwill impairment
    		                                                  
      purchases of treasury stock
    		               -1,000,000 -48,000,000 -61,000,000 -18,000,000 -50,000,000 0 -203,000,000 -19,000,000 -162,000,000 -95,000,000 -41,000,000 -480,000,000 -38,183,000 -1,202,000 -2,343,000 -20,243,000 -1,876,000 -3,116,000 -3,005,000 -26,058,000 -1,001,000 -2,326,000 -147,036,000 -12,139,000 -57,652,000 -16,013,000          
      proceeds from borrowings on the rjf credit facility
    		                       0 0 0 300,000,000 0 0 0 300,000,000                    
      repayment of borrowings on the rjf credit facility
    		                           0 0                      
      premium and discount amortization on available-for-sale securities and loss on other investments
    		                -2,000,000 15,000,000 -1,000,000 4,000,000 10,000,000 35,000,000 8,000,000    3,000,000                        
      assets segregated pursuant to regulations excluding cash and cash equivalents
    		                2,250,000,000 -2,501,000,000 -2,749,000,000                                
      brokerage client receivables and other accounts receivable
    		                -302,000,000 -377,000,000 254,000,000 1,000,000 329,000,000 -391,000,000 188,000,000 17,000,000 92,000,000 141,000,000 446,000,000 -373,135,000 -23,718,000 -249,031,000 123,512,000 24,965,000 -99,115,000 -68,177,000 91,410,000 -566,535,000 86,929,000 -388,553,000 246,998,000 -53,304,000 -262,972,000 -149,647,000  -297,824,000 -87,975,000 69,322,000 162,452,000 -87,369,000 -157,292,147 46,147 
      brokerage client payables and other accounts payable
    		                -798,000,000 518,000,000 4,953,000,000 865,000,000 -1,316,000,000 2,472,000,000 465,000,000 69,000,000 -212,000,000 -846,000,000 -242,000,000 529,742,000 -954,025,000 303,516,000 466,763,000 -484,084,000 -217,940,000 76,303,000 -507,562,000 1,219,188,000 -34,392,000 555,888,000 76,620,000 462,762,000 74,902,000 183,916,000 -340,578,000 -167,311,000 -58,509,000 141,531,000 929,177,000 -7,640,000 390,588,220 66,780 
      net increase in cash and cash equivalents, including those segregated pursuant to regulations
    		                1,589,000,000 -1,121,000,000 1,762,000,000                                
      cash and cash equivalents, including those segregated pursuant to regulations at beginning of year
    		                0 0 9,634,000,000                                
      cash and cash equivalents, including those segregated pursuant to regulations at end of period
    		                1,589,000,000 -1,121,000,000 11,396,000,000                                
      cash and cash equivalents segregated pursuant to regulations
    		                1,458,000,000 -1,595,000,000 6,019,000,000 1,039,000,000 -840,000,000 1,464,000,000 2,581,000,000                            
      total cash and cash equivalents, including those segregated pursuant to regulations at end of period
    		                1,589,000,000 -1,121,000,000 11,396,000,000                                
      non-cash right-of-use (“rou”) assets recorded for new and modified leases
    		                20,000,000 31,000,000 50,000,000                                
      acquisitions of and distributions to noncontrolling interests
    		                   1,000,000    -3,000,000                           
      provisions for loan losses, legal and regulatory proceedings and bad debts
    		                   48,000,000 85,000,000 123,000,000 1,000,000 14,000,000 7,000,000 6,000,000 32,000,000 21,004,000 19,777,000 4,637,000 9,265,000                    
      raymond james financial, inc. and subsidiariesconsolidated statements of cash flows
    		                                                  
      repayments of short-term borrowings
    		                                      -115,000,000            
      acquisition-related contingent consideration paid
    		                                                  
      net increase/(decrease) in cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations
    		                                                  
      cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at beginning of year
    		                   0 0 0 5,971,000,000                            
      cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of year
    		                                                  
      total cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of year
    		                                                  
      securities purchased under agreements to resell, net of securities sold under agreements to repurchase
    		                    -47,000,000 205,000,000 68,000,000  -8,000,000 7,000,000 -60,000,000 42,284,000 76,758,000 -228,749,000 104,290,000                    
      securities loaned, net of securities borrowed
    		                    10,000,000 -250,000,000 -47,000,000     -54,779,000 81,489,000 35,173,000 -140,229,000 -32,277,000                   
      proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale
    		                    41,000,000 82,000,000 -91,000,000  4,000,000 -25,000,000 48,000,000  -26,290,000 69,641,000 -108,470,000 144,863,000 -33,396,000 42,603,000 35,162,000       -3,609,000         
      business acquisition, net of cash acquired
    		                            0 0 -159,200,000           0 23,010,000        
      repayments of borrowings on the rjf credit facility
    		                                                  
      net increase in cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations
    		                    -5,856,000,000 8,003,000,000 719,000,000                            
      cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of period
    		                    -5,856,000,000 8,003,000,000 6,690,000,000                            
      total cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of period
    		                    -5,856,000,000 8,003,000,000 6,690,000,000                            
      raymond james financial, inc. and subsidiariescondensed consolidated statements of cash flows
    		                                                  
      distributions to noncontrolling interests
    		                           -3,062,000 -8,121,000 -3,000 -5,977,000 -3,601,000                   
      proceeds from/(repayments of) short-term borrowings
    		                      6,000,000       -330,000,000 -280,000,000                    
      premium and discount amortization on available-for-sale securities and (gain)/loss on other investments
    		                                                  
      securities sold under agreements to repurchase, net of securities purchased under agreements to resell
    		                                                  
      jay peak matter payments
    		                                                  
      proceeds from senior note issuances, net of debt issuance costs paid
    		                               -16,000                   
      premium paid on extinguishment of senior notes payable
    		                                                  
      acquisition-related contingent consideration (paid)/received
    		                                                  
      net increase/(decrease) in cash, cash equivalents, and cash segregated pursuant to regulations
    		                       19,000,000 -167,000,000                          
      cash, cash equivalents, and cash segregated pursuant to regulations at beginning of year
    		                       0 0 0 5,941,000,000                        
      cash, cash equivalents, and cash segregated pursuant to regulations at end of year
    		                                                  
      cash segregated pursuant to regulations
    		                       -342,000,000 68,000,000 -494,000,000 2,782,000,000                        
      total cash, cash equivalents, and cash segregated pursuant to regulations at end of year
    		                                                  
      net income attributable to raymond james financial, inc.
    		                        259,000,000 261,000,000 249,000,000 262,748,000 232,258,000 242,847,000 118,842,000 193,489,000 183,424,000 112,755,000 146,567,000 171,670,000 125,504,000 125,847,000 106,329,000 129,186,000 133,195,000 136,366,000 83,325,000 76,350,000 68,869,000 67,325,000 68,927,000 46,786,000 162,558,277 81,723 
      net income attributable to noncontrolling interests
    		                        -2,000,000 -12,000,000 -2,000,000    441,000   -4,210,000 1,136,000 -2,880,000 -6,315,000 -7,914,000 -6,163,000 -5,681,000 -6,835,000 -7,210,000 -6,927,000 13,121,000 -3,595,000 -6,203,000 -7,147,000 2,412,000 -5,763,232 -3,768 
      net income including noncontrolling interests
    		                        257,000,000 249,000,000 247,000,000 256,827,000 232,242,000 242,565,000 119,283,000 197,268,000 185,351,000 108,545,000 147,703,000 168,790,000 119,189,000 117,933,000 100,166,000 123,505,000 126,360,000 129,156,000 76,398,000 89,471,000 65,274,000 61,122,000 61,780,000 49,198,000 156,795,045 77,955 
      adjustments to reconcile net income including noncontrolling interests to net cash from operating activities:
    		                                                  
      securities borrowed, net of securities loaned
    		                        -363,000,000 297,000,000 22,000,000                        
      cash, cash equivalents, and cash segregated pursuant to regulations at end of period
    		                        -167,000,000 -985,000,000 7,104,000,000                        
      total cash, cash equivalents, and cash segregated pursuant to regulations at end of period
    		                        -167,000,000 -985,000,000 7,104,000,000                        
      repayments of other borrowed funds
    		                                      -1,091,000            
      see accompanying notes to condensed consolidated financial statements (unaudited).
    		                                                  
      net increase in cash, cash equivalents, and cash segregated pursuant to regulations
    		                          1,163,000,000                        
      net income/(loss) attributable to noncontrolling interests
    		                           -5,921,000 -16,000                      
      adjustments to reconcile net income including noncontrolling interests to net cash provided by/(used in) operating activities:
    		                                                  
      compensation expense/(benefit) payable in common stock of an acquiree
    		                           2,282,000 -3,577,000                      
      see accompanying notes to consolidated financial statements.
    		                                                  
      in thousands
    		                           0 0 1,000 2,017,000                    
      net increase/(decrease) in cash and cash equivalents
    		                           320,555,000 39,813,000   1,054,193,000                   
      cash and cash equivalents at beginning of year
    		                           0 0 0 3,669,672,000 0 0 0 1,650,452,000 0 0 0 2,601,006,000 0 0 0 0 0 0 2,439,695,000 0 0 2,940,295,761 2,943,239 
      cash and cash equivalents at end of year
    		                                                  
      premium and discount amortization on available-for-sale securities and loss/(gain) on other investments
    		                                                  
      unrealized gain on company owned life insurance, net of expenses
    		                            -4,925,000 2,127,000 -16,859,000                    
      assets segregated pursuant to regulations and other segregated assets
    		                            384,182,000 477,923,000 -96,759,000 -60,631,000 436,599,000 38,392,000 1,016,538,000 -1,190,414,000 -54,178,000 -538,128,000 -171,359,000 -392,238,000 47,363,000 -190,746,000 -65,173,000 864,538,000 46,829,000 43,490,000 -1,050,471,000 -91,343,000 1,024,219,623 1,363,377 
      additions to property, buildings and equipment, including software
    		                            -25,676,000 -34,489,000 -35,949,000                    
      acquisition-related contingent consideration received, net of payments
    		                               0                   
      cash and cash equivalents at end of period
    		                            39,813,000 -757,591,000 3,897,529,000  -20,847,000 108,051,000 2,528,275,000  498,271,000 -1,116,602,000 2,596,388,000  41,944,000   -1,146,823,000 958,904,000 1,916,954,000  343,520,000 1,253,963,117 1,204,883 
      premium and discount amortization on available-for-sale securities and unrealized gain on other investments
    		                             -4,818,000 -496,000 -4,104,000                   
      compensation expense payable in common stock of an acquiree
    		                              3,925,000                    
      net increase in cash and cash equivalents
    		                              227,857,000   108,051,000 877,823,000 -327,605,000 498,271,000 -1,116,602,000 -4,618,000 18,925,000 41,944,000 -646,694,000         
      provisions for loan losses, legal and regulatory proceedings (excluding the jay peak matter) and bad debts
    		                                                  
      compensation expense/(benefit) which is payable in common stock of an acquiree
    		                                                  
      unrealized (gain)/loss on company owned life insurance, net of expenses
    		                                                  
      loss on extinguishment of senior notes payable
    		                                                  
      securities purchased under agreements to resell and other collateralized financings, net of securities sold under agreements to repurchase
    		                               76,856,000 55,900,000 -157,633,000 121,878,000 -98,339,000 59,531,000 -78,232,000 -18,345,000 23,139,000 27,373,000 19,560,000 -16,885,000 -199,141,000 13,262,000 -6,892,000 195,917,000 -77,335,000 -216,599,882 -178,118 
      purchases of federal home loan bank/federal reserve bank stock
    		                               -4,250,000 -4,250,000 -625,000 -4,250,000 0 0 -2,168,000 -1,063,000            
      proceeds from sales of or distributions received from private equity and other investments, net of purchases or contributions to private equity or other investments
    		                                                  
      compensation expense which is payable in common stock of an acquiree
    		                                                  
      prepaid expenses and other assets
    		                                -23,978,000 73,018,000 85,740,000 68,789,000 -170,698,000 54,158,000 75,873,000 47,237,000 -29,143,000 19,216,000 7,188,000 -21,987,000 46,049,000 -18,336,000 4,104,000 -28,642,000 11,120,129 -129 
      purchases, or contributions to private equity or other investments, net of proceeds from sales of, or distributions received from, private equity and other investments
    		                                                  
      repayment of senior notes payable
    		                                0   0               
      non-cash transfers of loans to other real estate owned
    		                                2,582,000 1,586,000 1,191,000 775,000 968,000 1,334,000 608,000 1,324,000 893,000 2,582,000 1,532,000 167,000 8,303,000 2,651,000 2,041,000 2,221,000 9,929,083 6,917 
      premium and discount amortization on available for sale securities and unrealized/realized gain on other investments
    		                                 -8,791,000 -10,185,000 -6,726,000 -14,432,000 -6,439,000 2,587,000 100,000 -21,366,000 -1,071,000 -14,240,000 -7,797,000 -12,033,000 -1,392,000 -1,243,000 -10,089,000 -1,668,516 -484 
      provisions for loan losses, legal proceedings, bad debts and other accruals
    		                                 110,976,000 33,017,000 11,372,000 -7,933,000 16,367,000 22,588,000 14,356,000 -2,391,000 11,190,000 5,926,000 17,041,000 3,082,000 6,556,000 8,514,000 14,105,000 30,005,207 14,793 
      stock loaned, net of stock borrowed
    		                                 -2,389,000 -233,019,000 8,142,000 11,439,000 67,161,000 65,959,000 81,895,000 44,034,000 -23,826,000 -29,811,000 -85,196,000 -92,376,000 -150,573,000 188,507,000 101,037,000 -136,173,296 -122,704 
      purchases, or contributions, to private equity or other investments, net of proceeds from sales of, or distributions received from, private equity and other investments
    		                                 34,531,000 16,924,000  23,212,000 -35,511,000 -25,128,000            
      purchases of available for sale securities
    		                                 -635,003,000 -377,235,000 -354,271,000 -21,255,000 -10,453,000 -77,223,000 -88,284,000  0 2,000 -137,497,000 -110,934,000 -950,000 -236,440,000 -496,000 -1,830,799 -1,201 
      available for sale securities maturations, repayments and redemptions
    		                                 59,329,000 56,647,000 30,238,000 22,994,000 21,102,000 21,627,000 17,848,000 18,054,000 18,395,000 27,329,000 84,480,000 21,351,000 40,029,000     
      proceeds from sales of available for sale securities
    		                                 25,533,000 7,308,000 9,532,000 0   1,000 84,737,000 22,474,000         
      other investing activities, net of proceeds received
    		                                 58,000 2,341,000 2,786,000               
      proceeds from (repayments of) short-term borrowings
    		                                 -158,400,000 208,400,000                
      (excess tax benefit) reduction of prior tax benefit from share-based payment arrangements
    		                                   -330,000               
      purchases or contributions, to private equity or other investments, net of proceeds from sales of, or distributions received from, private equity and other investments
    		                                                  
      (repayments of) proceeds from short-term borrowings
    		                                                  
      proceeds from senior note issuances, net of debt issuance costs
    		                                                  
      repayments of borrowings by consolidated variable interest entities which are real estate partnerships
    		                                   1,000 -7,104,000 0 -7,159,000 30,000 -9,800,000 0 2,000 -11,547,000 -1,000 -11,599,000     
      proceeds from capital contributed to and borrowings of consolidated variable interest entities which are real estate partnerships
    		                                       0 0 0 0 30,445,000 -20,977,000 21,078,000     
      excess tax benefit (reduction of prior tax benefit) from share-based payments
    		                                   330,000               
      excess tax benefits from share-based payment arrangements
    		                                     0 -34,791,000   710,000 -5,614,000 791,000 535,000 1,675,000     
      investments in real estate partnerships held by consolidated variable interest entities, net of other investing activity
    		                                     -5,500,000 -7,349,000  12,271,000 1,000 -659,000 -471,000 156,000 174,000     
      (repayments) proceeds of short-term borrowings
    		                                                  
      excess tax benefits from share-based payments
    		                                     0 34,791,000            
      goodwill impairment expense
    		                                                  
      (loans provided to) repayment of loans, to financial advisors
    		                                                  
      (purchases and originations of loans held for sale)/proceeds from sales of securitizations and loans held for sale
    		                                                  
      reduction of prior tax benefits/(excess tax benefits) from share-based payment arrangements
    		                                                  
      (purchases or contributions to private equity or other investments)/proceeds from sales of or distributions received from private equity and other investments
    		                                                  
      (repayments of)/proceeds from short-term borrowings
    		                                                  
      proceeds from federal home loan bank advances and other borrowed funds
    		                                                  
      purchase of additional equity interest in subsidiary
    		                                          0 0 0 -4,017,000     
      (reduction of prior tax benefits)/excess tax benefits, from share-based payments
    		                                                  
      (excess tax benefits) reduction of prior tax benefits from share-based payment arrangements
    		                                                  
      purchases of federal home loan bank/federal reserve bank stock, net of redemptions
    		                                                  
      proceeds from sales of, or distributions received from, private equity, and other investments, net of purchases, business acquisitions or contributions to private equity or other investments
    		                                                  
      proceeds from borrowed funds
    		                                        965,000 95,800,000 107,184,000    0    
      repayments of borrowed funds
    		                                        -44,495,000 -1,035,000 -124,966,000        
      excess tax benefits (reduction of prior tax benefits) from share-based payments
    		                                                  
      (purchases)/redemptions of federal home loan bank/federal reserve bank stock
    		                                                  
      (purchases of or contributions to)/sales proceeds or distributions received from, private equity and other investments
    		                                                  
      (purchases) redemptions of federal home loan bank/federal reserve bank stock
    		                                         -300,000         
      sales (purchases) of private equity and other investments
    		                                             3,845,000 15,707,000 -3,825,000   
      proceeds from issuance of shares in registered public offering
    		                                          0 591,000       
      purchase of treasury stock
    		                                          -371,000 -1,267,000 -2,168,000 -17,054,000 -16,113,000 -82,000 -6,910,739 -5,261 
      (loans provided to) repayments of loans, to financial advisors
    		                                                  
      sales of private equity and other investments
    		                                                  
      loans to financial advisors, brokerage client receivables and other accounts receivable
    		                                                  
      purchase and origination of loans held for sale, net of proceeds from sale of securitizations and loans held for sale
    		                                          31,057,000 -59,570,000 22,499,000 -12,822,000 -64,560,000 -54,488,000 -19,508,132 -2,868 
      increase in loans
    		                                          -195,413,000 -294,310,000 -471,738,000 -489,970,000 -222,162,000   -48,760 
      redemptions (purchases) of federal home loan bank/federal reserve bank stock
    		                                                  
      (purchases) sales of private equity and other investments
    		                                          -63,820,000 -10,526,000       
      decrease in securities purchased under agreements to resell
    		                                                  
      acquisition of controlling interest in subsidiary
    		                                              0    
      increase in cash resulting from the consolidation of an acquired entity and the acquisition of a controlling interest in a subsidiary
    		                                                  
      loss benefit from auction rate securities
    		                                                  
      excess tax benefits from stock-based payment arrangements
    		                                           -791,000 -535,000 -1,675,000  -703,000 -1,068,707 -293 
      redemptions of federal home loan bank stock
    		                                             20,228,000     
      net decrease in cash and cash equivalents
    		                                             -522,741,000  325,154,000 -1,686,332,644 -1,738,356 
      (purchases) redemptions of federal home loan bank stock
    		                                                  
      proceeds from (repayments of) borrowed funds
    		                                                  
      repayments of borrowings
    		                                             -3,848,000 -831,000 -1,891,000 -2,556,074,205 -2,527,795 
      decrease in bank deposits
    		                                             -34,426,000  233,875,000 -368,737,678 -397,322 
      redemptions (purchases) of federal home loan bank stock
    		                                                  
      decrease (increase) in securities purchased under agreements to resell
    		                                                  
      investments in real estate partnerships held by variable interest entities, net of other investing activity
    		                                              -1,001,000 -9,722,000 -2,321,631 -4,369 
      increase in cash resulting from the consolidation/deconsolidation of certain entities
    		                                                  
      stock-based compensation expense
    		                                               5,928,000 27,025,168 15,832 
      redemption of federal home loan bank stock
    		                                               38,034,000 4,772,223 4,777 
      available for sale securities maturations and repayments
    		                                               25,434,000 66,580,462 34,538 
      sales of available for sale securities
    		                                               2,323,000 11,432,839 11,161 
      repayments of borrowings by variable interest entities which are real estate partnerships
    		                                               -11,820,000 -11,847,141 -11,859 
      proceeds from capital contributed to variable interest entities which are real estate partnerships
    		                                               15,384,000 17,513,804 14,196 
      decrease in loans
    		                                                  
      purchases of private equity and other investments
    		                                                 -8,648 
      decrease (increase) in loans
    		                                                  
      (purchase) redemption of federal home loan bank stock
    		                                                  
      proceeds from borrowings by variable interest entities which are real estate partnerships
    		                                                  
      cash increased (reduced) by consolidation/deconsolidation of certain partnerships and other entities
    		                                                  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.